Dry eye disease affects up to 15% of the U.S. population and is one of the largest markets in the ophthalmology field.

Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

Aldeyra Therapeutics has once again filed for Food and Drug Administration of its proposed reproxalap drug candidate for the treatment of signs and symptoms of dry-eye disease.

Depending on the severity of dry eye disease symptoms and their underlying causes, there are treatments that can help produce more tears, soothe your eyes and ease your discomfort. Treatments can ...

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today ...

Remember to blink. Thinking about blinking may feel silly, Dr. Moy said, but it’s a great way to prevent your eyes from ...

Tears evaporate and may cause dryness and irritation. Learn what evaporative dry eye is and what remedies to try for it.

Perimenopause is the period when women start experiencing menopausal symptoms; menopause is when periods stop due to lower ...

Aldeyra Therapeutics (ALDX) announced the resubmission of a New Drug Application to the FDA for topical ocular reproxalap, an ...

Patients with T2d with more severe peripheral neuropathy have a 4-fold DED risk compared with patients with mild or no peripheral neuropathy.